메뉴 건너뛰기




Volumn 205, Issue 2, 2012, Pages 228-236

Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in Newborns in Africa

Author keywords

[No Author keywords available]

Indexed keywords

MONOVALENT ORAL POLIOMYELITIS VACCINE TYPE 1; MONOVALENT ORAL POLIOMYELITIS VACCINE TYPE 3; ORAL POLIOMYELITIS VACCINE; TRIVALENT ORAL POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

EID: 84555178391     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir721     Document Type: Article
Times cited : (19)

References (38)
  • 1
    • 84555208917 scopus 로고
    • Global eradication of poliomyelitis by the year 2000
    • World Health Assembly Geneva: World Health Organization Accessed 10 March 2010
    • World Health Assembly. Global eradication of poliomyelitis by the year2000. Resolution of WHA 11.28. Geneva: World Health Organization, 1988; http://www.who.int/ihr/polioresolution4128en.pdf. Accessed 10 March 2010.
    • (1988) Resolution of WHA 11.28
  • 2
    • 0028272238 scopus 로고
    • Paralytic poliomyelitis: Seasoned strategies, disappearing disease
    • DOI 10.1016/S0140-6736(94)92472-4
    • Hull HF, Ward NA. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994; 343:1331-7. (Pubitemid 24162577)
    • (1994) Lancet , vol.343 , Issue.8909 , pp. 1331-1337
    • Hull, H.F.1    Ward, N.A.2    Hull, B.P.3    Milstien, J.B.4    De Quadros, C.5
  • 3
    • 84856077285 scopus 로고    scopus 로고
    • Strategy and work
    • Accessed 10 March 2010
    • Strategy and work. Global Polio Eradication Initiative Web site. http://www.polioeradication.org/Resourcelibrary/Strategyandwork.aspx. Accessed 10 March 2010.
    • Global Polio Eradication Initiative Web Site
  • 4
    • 84555208926 scopus 로고    scopus 로고
    • Progress in interrupting wild poliovirus transmission worldwide 2009
    • Progress in interrupting wild poliovirus transmission worldwide, 2009. Wkly Epidemiol Rec 2010; 85:177-84.
    • (2010) Wkly Epidemiol Rec , vol.85 , pp. 177-184
  • 5
    • 84856076885 scopus 로고    scopus 로고
    • Strategic plan of the Global Polio Eradication Initiative
    • Accessed 21 February 2011
    • Strategic plan of the Global Polio Eradication Initiative. Global Polio Eradication InitiativeWeb site. http://www.polioeradication.org/ResourceLibrary/ Strategyandwork/Strategicplan.aspx. Accessed 21 February 2011.
    • Global Polio Eradication InitiativeWeb Site
  • 7
    • 16644389952 scopus 로고    scopus 로고
    • Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva 21-22 September 2004
    • Conclusions and recommendations of the Ad Hoc Advisory Committee on Poliomyelitis Eradication, Geneva, 21-22 September 2004. Wkly Epidemiol Rec 2004; 79:401-8.
    • (2004) Wkly Epidemiol Rec , vol.79 , pp. 401-408
  • 8
    • 54049156876 scopus 로고    scopus 로고
    • Monovalent type 1 oral polio vaccine in newborns
    • El-Sayed N, El-Gamal Y, Abbassy A, et al. Monovalent type 1 oral polio vaccine in newborns. New Engl J Med 2008; 359:1655-65.
    • (2008) New Engl J Med , vol.359 , pp. 1655-1665
    • El-Sayed, N.1    El-Gamal, Y.2    Abbassy, A.3
  • 9
    • 79960560679 scopus 로고    scopus 로고
    • Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized doubleblind controlled clinical trials
    • John TJ, Jain H, Ravishankar K, et al. Monovalent type 1 oral poliovirus vaccine among infants in India: report of two randomized doubleblind controlled clinical trials. Vaccine 2011; 29:5793-801.
    • (2011) Vaccine , vol.29 , pp. 5793-5801
    • John, T.J.1    Jain, H.2    Ravishankar, K.3
  • 10
    • 78449268293 scopus 로고    scopus 로고
    • Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: A randomised, double-blind, controlled trial
    • Sutter RW, John TJ, Jain H, et al. Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial. Lancet 2010; 376:1682-8.
    • (2010) Lancet , vol.376 , pp. 1682-1688
    • Sutter, R.W.1    John, T.J.2    Jain, H.3
  • 12
    • 33644803364 scopus 로고    scopus 로고
    • Conclusions and recommendations of the advisory committee on poliomyelitis Eradication,Geneva 11-12 October 2005
    • Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva, 11-12 October 2005. Wkly Epidemiol Rec 2005; 80:409-16.
    • (2005) Wkly Epidemiol Rec , vol.80 , pp. 409-416
  • 13
    • 16544365158 scopus 로고    scopus 로고
    • Progress towards poliomyelitis eradication in Egypt , January 2003 to July 2004
    • Progress towards poliomyelitis eradication in Egypt, January 2003 to July 2004. Wkly Epidemiol Rec 2004; 79:313-20.
    • (2004) Wkly Epidemiol Rec , vol.79 , pp. 313-320
  • 14
    • 38349048149 scopus 로고    scopus 로고
    • Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication ,Geneva 27-28 November 2007
    • Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva, 27-28 November 2007. Wkly Epidemiol Rec 2008; 83:25-36.
    • (2008) Wkly Epidemiol Rec , vol.83 , pp. 25-36
  • 15
    • 84555206327 scopus 로고    scopus 로고
    • Outbreaks following importations of wild poliovirus into countries of the WHO African, European and South-East Asian Regions: January 2009-September 2010
    • Outbreaks following importations of wild poliovirus into countries of the WHO African, European and South-East Asian Regions: January 2009-September 2010. Wkly Epidemiol Rec 2010; 85: 445-52.
    • (2010) Wkly Epidemiol Rec , vol.85 , pp. 445-452
  • 16
    • 54049107358 scopus 로고    scopus 로고
    • Effective immunization against paralytic poliomyelitis in Nigeria
    • Jenkins HE, Aylward RB, Gasasira A, et al. Effective immunization against paralytic poliomyelitis in Nigeria. New Engl J Med 2008; 359:1666-74.
    • (2008) New Engl J Med , vol.359 , pp. 1666-1674
    • Jenkins, H.E.1    Aylward, R.B.2    Gasasira, A.3
  • 17
    • 77954900276 scopus 로고    scopus 로고
    • Progress towards eradicating poliomyelitis in Nigeria,January 2009-June 2010
    • Progress towards eradicating poliomyelitis in Nigeria, January 2009-June 2010. Wkly Epidemiol Rec 2010; 85:273-80.
    • (2010) Wkly Epidemiol Rec , vol.85 , pp. 273-280
  • 20
    • 0021601172 scopus 로고
    • Immune response of neonates to oral poliomyelitis vaccine
    • John TJ. Immune response of neonates to oral poliomyelitis vaccine. Br Med J 1984; 289:881. (Pubitemid 14006117)
    • (1984) British Medical Journal , vol.289 , Issue.6449 , pp. 881
    • John, T.J.1
  • 21
    • 0022871163 scopus 로고
    • Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin
    • De-Xiang D, Xi-min H, Wan-Jun L, et al. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Bull World Health Organ 1986; 64:853-60.
    • (1986) Bull World Health Organ , vol.64 , pp. 853-860
    • De-Xiang, D.1    Xi-Min, H.2    Wan-Jun, L.3
  • 22
    • 70349090302 scopus 로고
    • Expanded program on immunization poliomyelitis control
    • Expanded Program on Immunization. Poliomyelitis control. Wkly Epidemiol Rec 1985; 60:13-6.
    • (1985) Wkly Epidemiol Rec , vol.60 , pp. 13-6
  • 23
    • 77953624004 scopus 로고    scopus 로고
    • Polio vaccines and polio immunization in the pre-eradication era: WHO position paper
    • Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec 2010; 85:213-18.
    • (2010) Wkly Epidemiol Rec , vol.85 , pp. 213-218
  • 26
    • 4043130376 scopus 로고    scopus 로고
    • Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children
    • DOI 10.1016/S1473-3099(04)01106-5, PII S1473309904011065
    • Obaro SK, Pugatch D, Luzuriaga K. Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. Lancet Infect Dis 2004; 4:510-18. (Pubitemid 39077921)
    • (2004) Lancet Infectious Diseases , vol.4 , Issue.8 , pp. 510-518
    • Obaro, S.K.1    Pugatch, D.2    Luzuriaga, K.3
  • 27
    • 47349113252 scopus 로고    scopus 로고
    • Immunization in patients with HIV infection: Are practical recommendations possible?
    • DOI 10.2165/00003495-200868110-00001
    • Eley B. Immunization in patients with HIV infection: are practical recommendations possible? Drugs 2008; 68:1473-81. (Pubitemid 352001185)
    • (2008) Drugs , vol.68 , Issue.11 , pp. 1473-1481
    • Eley, B.1
  • 29
    • 84856075595 scopus 로고    scopus 로고
    • Clarification of the Expanded Programme on Immunisation-SA (EPI-SA)
    • 8 March Accessed 11 November 2011
    • Ngcobo N. Clarification of the Expanded Programme on Immunisation-SA (EPI-SA). ECDOH News. 8 March 2007. http://www.ecdoh.gov.za/press-releases/78/ Clarification-on-the-Expanded-Programme-on-ImmunisationSA-EPISA-Schedule/ 08-March-2007. Accessed 11 November 2011.
    • (2007) ECDOH News
    • Ngcobo, N.1
  • 31
    • 16944366445 scopus 로고    scopus 로고
    • Combined immunization of infants with oral and inactivated poliovirus vaccines: Results of a randomized trial in the Gambia, Oman and Thailand
    • WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines
    • WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman and Thailand. J Infect Dis 1997; 175(Suppl 1):215-27.
    • (1997) J Infect Dis , vol.175 , Issue.SUPPL. 1 , pp. 215-227
  • 32
    • 0004282518 scopus 로고
    • version 6.4 4th ed. Cary, NC: SAS Institute
    • SAS/STAT user's guide, version 6.4. 4th ed. Vol 1. Cary, NC: SAS Institute, 1989.
    • (1989) SAS/STAT User's Guide , vol.1
  • 33
    • 84856071686 scopus 로고    scopus 로고
    • R: A language and environment for computing
    • R Development Core Team Accessed 18 December 2006
    • R Development Core Team. R: a language and environment for computing. Vienna, Austria: R Foundation for Statistical Computing, 2006. http://www.R-project.org Accessed 18 December 2006.
    • (2006) Vienna Austria: R Foundation for Statistical Computing
  • 34
    • 12644276734 scopus 로고
    • Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type 1 vaccine at birth
    • Sabin AB, Michaels RH, Ziring P, et al. Effect of oral poliovirus vaccine in newborn children. II. Intestinal resistance and antibody response at 6 months in children fed type 1 vaccine at birth. Pediatrics 1963; 31: 641-50.
    • (1963) Pediatrics , vol.31 , pp. 641-650
    • Sabin, A.B.1    Michaels, R.H.2    Ziring, P.3
  • 35
    • 0035971173 scopus 로고    scopus 로고
    • Apparent global interruption of wild poliovirus type 2 transmission
    • Apparent global interruption of wild poliovirus type 2 transmission. MMWR Morb Mortal Wkly Rep 2001; 50:222-4.
    • (2001) MMWR Morb Mortal Wkly Rep , vol.50 , pp. 222-224
  • 36
  • 37
    • 77955866520 scopus 로고    scopus 로고
    • Improving the performance of enteric vaccines in the developing world
    • Serazin AC, Shackelton LA, Wilson C, Bhan MK. Improving the performance of enteric vaccines in the developing world. Nat Immunol 2010; 11:769-73.
    • (2010) Nat Immunol , vol.11 , pp. 769-773
    • Serazin, A.C.1    Shackelton, L.A.2    Wilson, C.3    Bhan, M.K.4
  • 38
    • 84856070292 scopus 로고    scopus 로고
    • Monovalent oral polio vaccines
    • Accessed 5 July 2011
    • Monovalent oral polio vaccines. Global Polio Eradication Initiative Web site. http://www.polioeradication.org/Polioandprevention/Thevaccines/ MonovalentOPV.aspx. Accessed 5 July 2011.
    • Global Polio Eradication Initiative Web Site


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.